Gelonghui November 27 | Yiling Pharmaceutical (002603.SZ) has been rising for 3 days, now up 3.54% to 26.89 yuan. The stock price hit a new high in nearly half a year, with a total market value of 44.93 billion yuan. Yiling Pharmaceutical recently announced that Beijing Yiling, a wholly-owned subsidiary of the company, has received a “Notice of Acceptance” issued by the State Drug Administration, and that the registration application for the new drug “Xinqi Tongtong Nose Tablets” submitted by Beijing Yiling has been officially accepted. Xinqi Nose Relief Tablets are a Class 1.1 traditional Chinese medicine innovative drug independently developed by the company. Its functional treatment is: it boosts qi, fixes the meter, and strengthens the spleen. It is used for persistent allergic rhinitis, pulmonary spleen failure, and symptoms such as sneezing, runny nose, nasal congestion, itchy nose, self-sweating, bad wind, fatigue, lack of breath, slurred speech, etc., pale tongue, white moss, or weak pulse.